Actively Recruiting
Epididymis Protein 4 and Pulmonary Function With Quality Improvement Protocol Among Cystic Fibrosis Patients
Led by Ain Shams University · Updated on 2025-04-08
35
Participants Needed
1
Research Sites
61 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To implement a quality improvement plan aimed at achieving a 5% increase in the Forced expiratory volume in 1st second (FEV1) (% predicted value) in cystic fibrosis (CF) patients with impaired pulmonary function parameters over 12 months. Additionally, the plan aims to measure serum human epididymis protein 4 (HE4) levels in the studied subjects before and after pulmonary function improvement.
CONDITIONS
Official Title
Epididymis Protein 4 and Pulmonary Function With Quality Improvement Protocol Among Cystic Fibrosis Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pediatric cystic fibrosis patients diagnosed based on Consensus Guidelines from the Cystic Fibrosis Foundation, with a positive sweat chloride test (≥60 milliequivalent/L) and/or two cystic fibrosis disease-causing gene mutations
- Age 6 years or older
- Forced expiratory volume in 1 second (FEV1) 80% or less
You will not qualify if you...
- Patients unable to perform spirometry
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ain Shams university
Cairo, Abbasia, Egypt, 00202
Actively Recruiting
Research Team
E
Eman Fawzy, MD
CONTACT
T
Terez Boshra
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here